mortality/aging
• most mice die between 10 and 12 months of age
|
behavior/neurological
• mice at 6 months of age show motor activity deficits and 100% of mice at 1 year of age develop rigidity, postural instability, and immobility
|
• seen around 8 months of age
|
• mice at 1 year of age show postural instability
|
• mice develop gait abnormalities, such as jerky movements at around 8 months of age
|
bradykinesia
(
J:212732
)
• mice develop bradykinesia at around 8 months of age and show progressive deterioration of motor activity to complete immobility by 12 months of age
|
spasticity
(
J:212732
)
• mice begin to show spasticity around 6 months of age
|
nervous system
• apoptosis of nigral neurons and cortical neruons
|
• agyrophilic degeneration in the red nucleus, superior cerebellar peduncle, medial lemniscus, and cerebral peduncle
|
• striatal interneuron degeneration
• cerebellar interneurons degenerate early in the course of disease
|
• degeneration of the ventral midbrain
|
• about 60% loss of neurons in the substantia nigra pars compacta
|
• apoptotic cells and loss of magnocellular neurons are seen in the red nucleus at endstage disease
|
• motor thalamus degeneration; nuclear-specific degeneration is seen in the ventral anterior and ventrolateral nucleus thalamic nuclei and the central medial, central lateral, and paracentral thalamic nuclie are also affected
|
• approximate 40% loss of neurons in the ventral anterior and/or ventral lateral thalamic nuclei of 12 month old mice
|
• modest neuropil punctate degeneration in the stratum radiatum of CA3 and stratum lacunosum-moleculare of CA1 of the hippocampus
|
• degeneration of the cerebral cortex
• ventricular system in the cerebral cortex is dilated at endstage disease
• thinning of the cortical mantle
• cell death is increased in layer V of the cerebral cortex at 8 and 12 months of age
|
• enhanced autophagy in cortical pyramidal neurons
|
• reduction in the thickness of the sensorimotor cortical gray matter
• mice at endstage disease show degeneration of the deep cerebellar nuclei
|
• reduction in the thickness of the subcortical white matter
|
• agyrophilic degeneration in the superior cerebellar peduncle
|
• degenerating cell bodies are seen in the granule cell layer, apoptotic cells in the molecular layers and terminal degeneration at the granule cell layer-Purkinje cell layer border as early as 1 month of age
|
• degeneration of cerebellar interpositus nucleus
|
• nigral neuron degeneration, with about 60% loss of neurons
• apoptotic degeneration of interneurons of young mice, with degeneration of striatal and cerebellar interneurons
• about 60% loss of red nucleus neurons at endstage disease
• approximate 40% loss of neurons in the ventral anterior and/or ventral lateral thalamic nuclei of 12 month old mice
|
• some degenerating substantia nigra pars compacta neurons show cytoplasmic Lewy-body-like inclusions
|
• cortical neurons show cytoplasmic and intranuclear aggregates of human synuclien protein
|
• axonal degeneration in the cortical gray matter and subcortical white matter and in the cerebral peduncle
• axonal and punctate degeneration in the red nucleus and intermingling superior cerebellar peduncle
|
cellular
• apoptosis of nigral neurons and cortical neruons
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
Parkinson's disease 1 | DOID:0060367 |
OMIM:168601 |
J:212732 |